Regulatory News
Monday, September 12, 2016
FDA staff flags concerns about Pfizer's quit-smoking drug study
Sept 12 (Reuters) - U.S. Food and Drug Administration
scientists have expressed concerns about a post-marketing study
of Pfizer Inc's drug Chantix, which is aimed at helping
smokers quit, according...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment